DUSP9-mediated reduction of pERK1/2 supports cancer stem cell-like traits and promotes triple negative breast cancer.
DUSP9
ERK1/2
Triple negative breast cancer
cancer stem cells
Journal
American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
07
2020
accepted:
13
09
2020
entrez:
9
11
2020
pubmed:
10
11
2020
medline:
10
11
2020
Statut:
epublish
Résumé
Breast cancer remains a complex disease resulting in high mortality in women. A subset of cancer stem cell (CSC)-like cells expressing aldehyde dehydrogenase 1 (ALDH1) and SOX2/OCT4 are implicated in aggressive biology of specific subtypes of breast cancer. Targeting these populations in breast tumors remain challenging. We examined xenografts from three poorly studied triple negative (TN) breast cancer cells (MDA-MB-468, HCC70 and HCC1806) as well as HMLE
Types de publication
Journal Article
Langues
eng
Pagination
3487-3506Subventions
Organisme : NCI NIH HHS
ID : SC1 CA165865
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007598
Pays : United States
Organisme : NIA NIH HHS
ID : SC1 AG049682
Pays : United States
Organisme : NCI NIH HHS
ID : SC1 CA232319
Pays : United States
Organisme : NIMHD NIH HHS
ID : S21 MD000103
Pays : United States
Informations de copyright
AJCR Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
Dev Biol. 1999 Jun 1;210(1):30-43
pubmed: 10364425
Cancer Cell. 2004 Apr;5(4):375-87
pubmed: 15093544
Mol Cell. 2015 Nov 19;60(4):537-46
pubmed: 26590713
Cell. 2014 Sep 11;158(6):1254-1269
pubmed: 25215486
Cell Rep. 2015 Jun 16;11(10):1549-63
pubmed: 26051943
J Proteomics. 2013 Dec 6;94:497-512
pubmed: 24332066
BMC Cancer. 2011 Sep 26;11:413
pubmed: 21943117
Genes Dev. 2001 Jan 1;15(1):50-65
pubmed: 11156605
Cell Stem Cell. 2012 Feb 3;10(2):171-82
pubmed: 22305567
Breast Cancer Res. 2008;10(3):R53
pubmed: 18559090
Asian Pac J Cancer Prev. 2016;17(S3):43-6
pubmed: 27165206
Nature. 2010 Nov 25;468(7323):567-71
pubmed: 21107427
Mol Oncol. 2018 Nov;12(11):1838-1855
pubmed: 30133130
Cancer Res. 2009 Jan 15;69(2):565-72
pubmed: 19147570
J Clin Oncol. 2015 Dec 20;33(36):4267-76
pubmed: 26598753
Biochem Biophys Res Commun. 2017 Aug 5;489(4):484-489
pubmed: 28576487
Mol Cancer Ther. 2016 Nov;15(11):2598-2608
pubmed: 27528706
Cancer Res. 2010 Mar 15;70(6):2264-73
pubmed: 20215513
Breast Cancer Res Treat. 2017 Nov;166(2):421-433
pubmed: 28791489
Cancer Lett. 2003 Mar 10;191(2):229-37
pubmed: 12618338
Carcinogenesis. 2016 Jan;37(1):49-55
pubmed: 26577839
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Oncol Rep. 2015 Nov;34(5):2423-30
pubmed: 26329166
Cancer Metastasis Rev. 2016 Dec;35(4):515-524
pubmed: 27896521
Sci Rep. 2016 Dec 15;6:38045
pubmed: 27974826
Cancer Res. 2012 Jan 1;72(1):365-74
pubmed: 22086849
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690
pubmed: 27184417
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Int J Oncol. 2012 Jan;40(1):130-8
pubmed: 21904773
Cancer Cell. 2019 Apr 15;35(4):618-632.e6
pubmed: 30930118
Clin Cancer Res. 2011 May 15;17(10):3193-203
pubmed: 21325073
Cancer Res. 2013 Dec 15;73(24):7290-300
pubmed: 24142344
Cell Stem Cell. 2007 Nov;1(5):555-67
pubmed: 18371393
J Biol Chem. 2017 Mar 10;292(10):3970-3976
pubmed: 28179426
J Biol Chem. 2008 Jun 27;283(26):17969-78
pubmed: 18456656
PLoS One. 2014 Aug 14;9(8):e104987
pubmed: 25122124
Clin Breast Cancer. 2009 Jun;9 Suppl 2:S73-81
pubmed: 19596646
Development. 2009 Oct;136(19):3215-22
pubmed: 19710168
BioData Min. 2013 Oct 15;6(1):17
pubmed: 24128261
Cancer Res. 2007 Nov 15;67(22):10711-9
pubmed: 18006813
Genome Biol. 2002 Jun 26;3(7):REVIEWS3009
pubmed: 12184814
Oncogene. 2014 Jan 30;33(5):643-52
pubmed: 23318426
Anticancer Res. 2012 May;32(5):1627-37
pubmed: 22593441
Int J Oncol. 2018 Jun;52(6):2069-2078
pubmed: 29620155
Br J Cancer. 2013 Mar 5;108(4):848-58
pubmed: 23403820
Nat Genet. 2008 May;40(5):499-507
pubmed: 18443585
FEBS Open Bio. 2014 Feb 21;4:213-9
pubmed: 24649403
Pathol Res Pract. 2015 Oct;211(10):740-7
pubmed: 26298632
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62
pubmed: 24114568
J Cell Biochem. 2015 Dec;116(12):2778-85
pubmed: 25959272
Anal Biochem. 2009 Nov 1;394(1):81-6
pubmed: 19583964
Cancer Res. 2013 Oct 15;73(20):6346-58
pubmed: 23966295
PLoS One. 2015 Aug 21;10(8):e0135851
pubmed: 26295469
Genes Dev. 2003 May 15;17(10):1253-70
pubmed: 12756227
Breast Cancer Res. 2013;15(5):R76
pubmed: 24008056
BMC Cancer. 2016 Jul 29;16:559
pubmed: 27473585
Int J Oncol. 2017 Dec;51(6):1685-1693
pubmed: 29039514
Oncotarget. 2017 May 30;8(22):36305-36318
pubmed: 28422735
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
Mol Cancer Res. 2016 Jan;14(1):78-92
pubmed: 26464213